Fluorescence Imaging: Clinical Trials

4 trials of Fluorescence Imaging, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 recruiting. 4 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Completed 2, Recruiting 2
Phase 22Completed 1, Recruiting 1

Follow Fluorescence Imaging: new trials by email Literature Review of Fluorescence Imaging trials Research Report on Fluorescence Imaging

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluating the Use of Dual Imaging Techniques for Detection of Disease in Patients With Head and Neck Cancer
Panitumumab-IRDye800, Indium In 111 Panitumumab, Single Photon Emission Computed Tomography - Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma
Phase 1RecruitingVanderbilt-Ingram Cancer Center402023-10-032025-10-03
Fluorescence Imaging With Indocyanine Green(ICG) in Endoscopic Spinal Surgery
Indocyanine Green, Fluorescence imaging - Disc Herniation
Phase 1 / Phase 2CompletedZhongnan Hospital402023-04-112025-12-19
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Fluorescence Imaging, Panitumumab, Panitumumab-IRDye800 - Pancreatic Adenocarcinoma
Phase 1 / Phase 2RecruitingGeorge Poultsides272018-02-072026-03-17
Fluorescence Imaging in Finding Tumors in Patients With Kidney Tumors
fluorescence imaging, laparoscopic surgery, indocyanine green - Recurrent Renal Cell Cancer, Stage I Renal Cell Cancer
Phase 1CompletedCity of Hope Medical Center282011-10-202017-10-13

Conditions studied

Carcinoma, Renal Cell (1)  ·  Intervertebral Disc Displacement (1)  ·  Squamous Cell Carcinoma of Head and Neck (1)

Sponsors

City of Hope Medical Center (1)  ·  George Poultsides (1)  ·  Vanderbilt-Ingram Cancer Center (1)  ·  Zhongnan Hospital (1)

Countries

United States (3)  ·  China (1)

Top investigators

Clayton Lau, MD (1)  ·  Eben Rosenthal, MD (1)  ·  George Poultsides (1)  ·  Yuanlong Xie, M.D. (1)

Results publications

PMID 32416764, PMID 41498537

NIH funding

R01CA190306 (1), R01CA266233 (1)